The global Antisense and RNA Interference Therapeutics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Antisense and RNA Interference Therapeutics manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Antisense and RNA Interference Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense and RNA Interference Therapeutics. This report contains market size and forecasts of Antisense and RNA Interference Therapeutics in global, including the following market information:
Global Antisense and RNA Interference Therapeutics market revenue, 2020-2025, 2026-2032, ($ millions)
Global Antisense and RNA Interference Therapeutics market sales, 2020-2025, 2026-2032, (K Units)
Global top five Antisense and RNA Interference Therapeutics companies in 2024 (%)
Total Market by Segment:
Global Antisense and RNA Interference Therapeutics market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Antisense and RNA Interference Therapeutics market segment percentages, by Type, 2024 (%)
RNA
Antisense RNA
Global Antisense and RNA Interference Therapeutics market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Antisense and RNA Interference Therapeutics market segment percentages, by Application, 2024 (%)
General Hospitals
Specialty Clinics
Global Antisense and RNA Interference Therapeutics market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Antisense and RNA Interference Therapeutics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antisense and RNA Interference Therapeutics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Antisense and RNA Interference Therapeutics revenues share in global market, 2024 (%)
Key companies Antisense and RNA Interference Therapeutics sales in global market, 2020-2025 (estimated), (K Units)
Key companies Antisense and RNA Interference Therapeutics sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Antisense Therapeutics
Arbutus Biopharma
Ionis Pharmaceuticals
F. Hoffmann-La Roche
Santaris
Silence Therapeutics
Sirnaomics
Tekmira Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antisense and RNA Interference Therapeutics, market overview.
Chapter 2: Global Antisense and RNA Interference Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Antisense and RNA Interference Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antisense and RNA Interference Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antisense and RNA Interference Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antisense and RNA Interference Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Antisense and RNA Interference Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antisense and RNA Interference Therapeutics Overall Market Size
2.1 Global Antisense and RNA Interference Therapeutics Market Size: 2024 VS 2032
2.2 Global Antisense and RNA Interference Therapeutics Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Antisense and RNA Interference Therapeutics Sales: 2020-2032
3 Company Landscape
3.1 Top Antisense and RNA Interference Therapeutics Players in Global Market
3.2 Top Global Antisense and RNA Interference Therapeutics Companies Ranked by Revenue
3.3 Global Antisense and RNA Interference Therapeutics Revenue by Companies
3.4 Global Antisense and RNA Interference Therapeutics Sales by Companies
3.5 Global Antisense and RNA Interference Therapeutics Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Antisense and RNA Interference Therapeutics Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Antisense and RNA Interference Therapeutics Product Type
3.8 Tier 1, Tier 2, and Tier 3 Antisense and RNA Interference Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Antisense and RNA Interference Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Antisense and RNA Interference Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Antisense and RNA Interference Therapeutics Market Size Markets, 2024 & 2032
4.1.2 RNA
4.1.3 Antisense RNA
4.2 Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue & Forecasts
4.2.1 Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue, 2020-2025
4.2.2 Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue, 2026-2032
4.2.3 Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Antisense and RNA Interference Therapeutics Sales & Forecasts
4.3.1 Segment by Type - Global Antisense and RNA Interference Therapeutics Sales, 2020-2025
4.3.2 Segment by Type - Global Antisense and RNA Interference Therapeutics Sales, 2026-2032
4.3.3 Segment by Type - Global Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
4.4 Segment by Type - Global Antisense and RNA Interference Therapeutics Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Antisense and RNA Interference Therapeutics Market Size, 2024 & 2032
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue & Forecasts
5.2.1 Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue, 2020-2025
5.2.2 Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue, 2026-2032
5.2.3 Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Antisense and RNA Interference Therapeutics Sales & Forecasts
5.3.1 Segment by Application - Global Antisense and RNA Interference Therapeutics Sales, 2020-2025
5.3.2 Segment by Application - Global Antisense and RNA Interference Therapeutics Sales, 2026-2032
5.3.3 Segment by Application - Global Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
5.4 Segment by Application - Global Antisense and RNA Interference Therapeutics Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Antisense and RNA Interference Therapeutics Market Size, 2024 & 2032
6.2 By Region - Global Antisense and RNA Interference Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Antisense and RNA Interference Therapeutics Revenue, 2020-2025
6.2.2 By Region - Global Antisense and RNA Interference Therapeutics Revenue, 2026-2032
6.2.3 By Region - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
6.3 By Region - Global Antisense and RNA Interference Therapeutics Sales & Forecasts
6.3.1 By Region - Global Antisense and RNA Interference Therapeutics Sales, 2020-2025
6.3.2 By Region - Global Antisense and RNA Interference Therapeutics Sales, 2026-2032
6.3.3 By Region - Global Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Antisense and RNA Interference Therapeutics Revenue, 2020-2032
6.4.2 By Country - North America Antisense and RNA Interference Therapeutics Sales, 2020-2032
6.4.3 United States Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.4.4 Canada Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.4.5 Mexico Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Antisense and RNA Interference Therapeutics Revenue, 2020-2032
6.5.2 By Country - Europe Antisense and RNA Interference Therapeutics Sales, 2020-2032
6.5.3 Germany Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5.4 France Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5.5 U.K. Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5.6 Italy Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5.7 Russia Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5.8 Nordic Countries Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.5.9 Benelux Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Antisense and RNA Interference Therapeutics Revenue, 2020-2032
6.6.2 By Region - Asia Antisense and RNA Interference Therapeutics Sales, 2020-2032
6.6.3 China Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.6.4 Japan Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.6.5 South Korea Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.6.6 Southeast Asia Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.6.7 India Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Antisense and RNA Interference Therapeutics Revenue, 2020-2032
6.7.2 By Country - South America Antisense and RNA Interference Therapeutics Sales, 2020-2032
6.7.3 Brazil Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.7.4 Argentina Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Sales, 2020-2032
6.8.3 Turkey Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.8.4 Israel Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.8.5 Saudi Arabia Antisense and RNA Interference Therapeutics Market Size, 2020-2032
6.8.6 UAE Antisense and RNA Interference Therapeutics Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Company Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals Antisense and RNA Interference Therapeutics Major Product Offerings
7.1.4 Alnylam Pharmaceuticals Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.1.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.2 Antisense Therapeutics
7.2.1 Antisense Therapeutics Company Summary
7.2.2 Antisense Therapeutics Business Overview
7.2.3 Antisense Therapeutics Antisense and RNA Interference Therapeutics Major Product Offerings
7.2.4 Antisense Therapeutics Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.2.5 Antisense Therapeutics Key News & Latest Developments
7.3 Arbutus Biopharma
7.3.1 Arbutus Biopharma Company Summary
7.3.2 Arbutus Biopharma Business Overview
7.3.3 Arbutus Biopharma Antisense and RNA Interference Therapeutics Major Product Offerings
7.3.4 Arbutus Biopharma Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.3.5 Arbutus Biopharma Key News & Latest Developments
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Company Summary
7.4.2 Ionis Pharmaceuticals Business Overview
7.4.3 Ionis Pharmaceuticals Antisense and RNA Interference Therapeutics Major Product Offerings
7.4.4 Ionis Pharmaceuticals Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.4.5 Ionis Pharmaceuticals Key News & Latest Developments
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Summary
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Antisense and RNA Interference Therapeutics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.5.5 F. Hoffmann-La Roche Key News & Latest Developments
7.6 Santaris
7.6.1 Santaris Company Summary
7.6.2 Santaris Business Overview
7.6.3 Santaris Antisense and RNA Interference Therapeutics Major Product Offerings
7.6.4 Santaris Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.6.5 Santaris Key News & Latest Developments
7.7 Silence Therapeutics
7.7.1 Silence Therapeutics Company Summary
7.7.2 Silence Therapeutics Business Overview
7.7.3 Silence Therapeutics Antisense and RNA Interference Therapeutics Major Product Offerings
7.7.4 Silence Therapeutics Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.7.5 Silence Therapeutics Key News & Latest Developments
7.8 Sirnaomics
7.8.1 Sirnaomics Company Summary
7.8.2 Sirnaomics Business Overview
7.8.3 Sirnaomics Antisense and RNA Interference Therapeutics Major Product Offerings
7.8.4 Sirnaomics Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.8.5 Sirnaomics Key News & Latest Developments
7.9 Tekmira Pharmaceuticals
7.9.1 Tekmira Pharmaceuticals Company Summary
7.9.2 Tekmira Pharmaceuticals Business Overview
7.9.3 Tekmira Pharmaceuticals Antisense and RNA Interference Therapeutics Major Product Offerings
7.9.4 Tekmira Pharmaceuticals Antisense and RNA Interference Therapeutics Sales and Revenue in Global (2020-2025)
7.9.5 Tekmira Pharmaceuticals Key News & Latest Developments
8 Global Antisense and RNA Interference Therapeutics Production Capacity, Analysis
8.1 Global Antisense and RNA Interference Therapeutics Production Capacity, 2020-2032
8.2 Antisense and RNA Interference Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Antisense and RNA Interference Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antisense and RNA Interference Therapeutics Supply Chain Analysis
10.1 Antisense and RNA Interference Therapeutics Industry Value Chain
10.2 Antisense and RNA Interference Therapeutics Upstream Market
10.3 Antisense and RNA Interference Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antisense and RNA Interference Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Antisense and RNA Interference Therapeutics in Global Market
Table 2. Top Antisense and RNA Interference Therapeutics Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Antisense and RNA Interference Therapeutics Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Antisense and RNA Interference Therapeutics Revenue Share by Companies, 2020-2025
Table 5. Global Antisense and RNA Interference Therapeutics Sales by Companies, (K Units), 2020-2025
Table 6. Global Antisense and RNA Interference Therapeutics Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Antisense and RNA Interference Therapeutics Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Antisense and RNA Interference Therapeutics Product Type
Table 9. List of Global Tier 1 Antisense and RNA Interference Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antisense and RNA Interference Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Antisense and RNA Interference Therapeutics Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Antisense and RNA Interference Therapeutics Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 21. By Region � Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 25. By Region - Global Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 26. By Country - North America Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 29. By Country - North America Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 30. By Country - Europe Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 33. By Country - Europe Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 34. By Region - Asia Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 37. By Region - Asia Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 38. By Country - South America Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 41. By Country - South America Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Sales, (K Units), 2026-2032
Table 46. Alnylam Pharmaceuticals Company Summary
Table 47. Alnylam Pharmaceuticals Antisense and RNA Interference Therapeutics Product Offerings
Table 48. Alnylam Pharmaceuticals Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Alnylam Pharmaceuticals Key News & Latest Developments
Table 50. Antisense Therapeutics Company Summary
Table 51. Antisense Therapeutics Antisense and RNA Interference Therapeutics Product Offerings
Table 52. Antisense Therapeutics Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Antisense Therapeutics Key News & Latest Developments
Table 54. Arbutus Biopharma Company Summary
Table 55. Arbutus Biopharma Antisense and RNA Interference Therapeutics Product Offerings
Table 56. Arbutus Biopharma Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Arbutus Biopharma Key News & Latest Developments
Table 58. Ionis Pharmaceuticals Company Summary
Table 59. Ionis Pharmaceuticals Antisense and RNA Interference Therapeutics Product Offerings
Table 60. Ionis Pharmaceuticals Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Ionis Pharmaceuticals Key News & Latest Developments
Table 62. F. Hoffmann-La Roche Company Summary
Table 63. F. Hoffmann-La Roche Antisense and RNA Interference Therapeutics Product Offerings
Table 64. F. Hoffmann-La Roche Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. F. Hoffmann-La Roche Key News & Latest Developments
Table 66. Santaris Company Summary
Table 67. Santaris Antisense and RNA Interference Therapeutics Product Offerings
Table 68. Santaris Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Santaris Key News & Latest Developments
Table 70. Silence Therapeutics Company Summary
Table 71. Silence Therapeutics Antisense and RNA Interference Therapeutics Product Offerings
Table 72. Silence Therapeutics Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Silence Therapeutics Key News & Latest Developments
Table 74. Sirnaomics Company Summary
Table 75. Sirnaomics Antisense and RNA Interference Therapeutics Product Offerings
Table 76. Sirnaomics Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Sirnaomics Key News & Latest Developments
Table 78. Tekmira Pharmaceuticals Company Summary
Table 79. Tekmira Pharmaceuticals Antisense and RNA Interference Therapeutics Product Offerings
Table 80. Tekmira Pharmaceuticals Antisense and RNA Interference Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Tekmira Pharmaceuticals Key News & Latest Developments
Table 82. Antisense and RNA Interference Therapeutics Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 83. Global Antisense and RNA Interference Therapeutics Capacity Market Share of Key Manufacturers, 2023-2025
Table 84. Global Antisense and RNA Interference Therapeutics Production by Region, 2020-2025 (K Units)
Table 85. Global Antisense and RNA Interference Therapeutics Production by Region, 2026-2032 (K Units)
Table 86. Antisense and RNA Interference Therapeutics Market Opportunities & Trends in Global Market
Table 87. Antisense and RNA Interference Therapeutics Market Drivers in Global Market
Table 88. Antisense and RNA Interference Therapeutics Market Restraints in Global Market
Table 89. Antisense and RNA Interference Therapeutics Raw Materials
Table 90. Antisense and RNA Interference Therapeutics Raw Materials Suppliers in Global Market
Table 91. Typical Antisense and RNA Interference Therapeutics Downstream
Table 92. Antisense and RNA Interference Therapeutics Downstream Clients in Global Market
Table 93. Antisense and RNA Interference Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antisense and RNA Interference Therapeutics Product Picture
Figure 2. Antisense and RNA Interference Therapeutics Segment by Type in 2024
Figure 3. Antisense and RNA Interference Therapeutics Segment by Application in 2024
Figure 4. Global Antisense and RNA Interference Therapeutics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Antisense and RNA Interference Therapeutics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Antisense and RNA Interference Therapeutics Revenue: 2020-2032 (US$, Mn)
Figure 8. Antisense and RNA Interference Therapeutics Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Antisense and RNA Interference Therapeutics Revenue in 2024
Figure 10. Segment by Type � Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Antisense and RNA Interference Therapeutics Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Antisense and RNA Interference Therapeutics Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 21. By Region - Global Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
Figure 22. By Country - North America Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 23. By Country - North America Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
Figure 24. United States Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
Figure 29. Germany Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 30. France Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Antisense and RNA Interference Therapeutics Sales Market Share, 2020-2032
Figure 38. China Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 42. India Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Antisense and RNA Interference Therapeutics Revenue Market Share, 2020-2032
Figure 44. By Country - South America Antisense and RNA Interference Therapeutics Sales, Market Share, 2020-2032
Figure 45. Brazil Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Antisense and RNA Interference Therapeutics Sales, Market Share, 2020-2032
Figure 49. Turkey Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Antisense and RNA Interference Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 53. Global Antisense and RNA Interference Therapeutics Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Antisense and RNA Interference Therapeutics by Region, 2024 VS 2032
Figure 55. Antisense and RNA Interference Therapeutics Industry Value Chain
Figure 56. Marketing Channels
